Literature DB >> 28882093

Sample size considerations for n-of-1 trials.

Stephen Senn1,2.   

Abstract

N-of-1 trials are trials in which patients are treated with two or more treatments on multiple occasions. They can have many different purposes and can be analysed in different frameworks. In this note, five different criteria for planning sample sizes for n-of-1 trials are identified, and formulae and advice to address the associated tasks are provided. The basic design addressed is that of randomisation to treatment and control within cycles of pairs of episodes and the model assumed is that of a Normal-Normal mixture with variance components corresponding to within-cycle within-patient variation and treatment-by-patient interaction. The code to accomplish the tasks has been written in GenStat®, SAS® and R® and the application of the approaches is illustrated.

Entities:  

Keywords:  Power; mixed models; precision; shrinkage estimator; within-patient study

Mesh:

Year:  2017        PMID: 28882093     DOI: 10.1177/0962280217726801

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  17 in total

Review 1.  Multicrossover Randomized Controlled Trial Designs in Alzheimer Disease.

Authors:  Steven E Arnold; Rebecca A Betensky
Journal:  Ann Neurol       Date:  2018-08-29       Impact factor: 10.422

2.  Determining sample size and length of follow-up for smartphone-based digital phenotyping studies.

Authors:  Ian Barnett; John Torous; Harrison T Reeder; Justin Baker; Jukka-Pekka Onnela
Journal:  J Am Med Inform Assoc       Date:  2020-12-09       Impact factor: 4.497

3.  Single case designs for early phase behavioral translational research in health psychology.

Authors:  Leonard H Epstein; Warren K Bickel; Susan M Czajkowski; Rocco A Paluch; Mariola Moeyaert; Karina W Davidson
Journal:  Health Psychol       Date:  2021-08-09       Impact factor: 4.267

Review 4.  Perspective: Application of N-of-1 Methods in Personalized Nutrition Research.

Authors:  Tilly Potter; Rute Vieira; Baukje de Roos
Journal:  Adv Nutr       Date:  2021-06-01       Impact factor: 8.701

5.  A Randomized Placebo-Controlled N-of-1 Trial: The Effect of Proton Pump Inhibitor in the Management of Gastroesophageal Reflux Disease.

Authors:  Fernando Sierra-Arango; D M Castaño; Jennifer D Forero; Erika D Pérez-Riveros; Gerardo Ardila Duarte; Maria L Botero; Andres Cárdenas; Jose De la Hoz-Valle
Journal:  Can J Gastroenterol Hepatol       Date:  2019-12-12

6.  Comparison of Aggregated N-of-1 Trials with Parallel and Crossover Randomized Controlled Trials Using Simulation Studies.

Authors:  J Walker Blackston; Andrew G Chapple; James M McGree; Suzanne McDonald; Jane Nikles
Journal:  Healthcare (Basel)       Date:  2019-11-06

7.  Some t-tests for N-of-1 trials with serial correlation.

Authors:  Jillian Tang; Reid D Landes
Journal:  PLoS One       Date:  2020-02-04       Impact factor: 3.240

8.  A pilot protocol to assess the feasibility of a virtual multiple crossover, randomized controlled trial design using methylphenidate in mild cognitive impairment.

Authors:  Libby A DesRuisseaux; Victoria J Williams; Alison J McManus; Anoopum S Gupta; Becky C Carlyle; Hamed Azami; Jessica A Gerber; Anna M Bolling; Carolyn L Cook; Rebecca A Betensky; Steven E Arnold
Journal:  Trials       Date:  2020-12-11       Impact factor: 2.279

Review 9.  Lessons learned from IDeAl - 33 recommendations from the IDeAl-net about design and analysis of small population clinical trials.

Authors:  Ralf-Dieter Hilgers; Malgorzata Bogdan; Carl-Fredrik Burman; Holger Dette; Mats Karlsson; Franz König; Christoph Male; France Mentré; Geert Molenberghs; Stephen Senn
Journal:  Orphanet J Rare Dis       Date:  2018-05-11       Impact factor: 4.123

10.  Modified Sijunzi decoction in the treatment of ulcerative colitis in the remission phase: study protocol for a series of N-of-1 double-blind, randomised controlled trials.

Authors:  Yi-Ming Chen; Jie-Min Deng; Yi Wen; Bin Chen; Jiang-Tao Hou; Bin Peng; Shi-Jing Zhang; Hong Mi; Qi-Long Jiang; Xia-Lin Wu; Feng-Bin Liu; Xin-Lin Chen
Journal:  Trials       Date:  2020-05-12       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.